The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, ad... von Finn, Richard S, MD, Crown, John P, Prof, Lang, Istvan, MD, Boer, Katalin, MD, Bondarenko, Igor M, Prof, Kulyk, Sergey O, MD, Ettl, Johannes, MD, Patel, Ravindranath, MD, Pinter, Tamas, MD, Schmidt, Marcus, MD, Shparyk, Yaroslav, MD, Thummala, Anu R, MD, Voytko, Nataliya L, MD, Fowst, Camilla, MD, Huang, Xin, PhD, Kim, Sindy T, BS, Randolph, Sophia, MD, Slamon, Dennis J, Prof

Volltext

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma von MOTZER, Robert J, HUTSON, Thomas E, GARCIA-DEL-MURO, Xavier, SOSMAN, Jeffrey A, SOLSKA, Ewa, WILDING, George, THOMPSON, John A, KIM, Sindy T, CHEN, Isan, XIN HUANG, FIGLIN, Robert A, TOMCZAK, Piotr, MICHAELSON, M. Dror, BUKOWSKI, Ronald M, OUDARD, Stéphane, NEGRIER, Sylvie, SZCZYLIK, Cezary, PILI, Roberto, BJARNASON, Georg A

Volltext

Antitumor Activity and Biomarker Analysis of Sunitinib in Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma von RINI, Brian I, DROR MICHAELSON, M, KIM, Sindy T, CHEN, Isan, GEORGE, Daniel J, ROSENBERG, Jonathan E, BUKOWSKI, Ronald M, SOSMAN, Jeffrey A, STADLER, Walter M, HUTSON, Thomas E, MARGOLIN, Kim, HARMON, Charles S, DEPRIMO, Samuel E

Volltext

Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Ca... von MOTZER, Robert J, MICHAELSON, M. Dror, LI, Jim Z, BELLO, Carlo L, THEUER, Charles P, GEORGE, Daniel J, RINI, Brian I, REDMAN, Bruce G, HUDES, Gary R, WILDING, George, FIGLIN, Robert A, GINSBERG, Michelle S, KIM, Sindy T, BAUM, Charles M, DEPRIMO, Samuel E

Volltext

Quality of Life in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib or Interferon Alfa: Results From a Phase III Randomized Trial von CELLA, David, LI, Jim Z, CAPPELLERI, Joseph C, BUSHMAKIN, Andrew, CHARBONNEAU, Claudie, KIM, Sindy T, CHEN, Isan, MOTZER, Robert J

Volltext

Economic Evaluation of Sunitinib Malate for the First-Line Treatment of Metastatic Renal Cell Carcinoma von REMDK, Edit, CHARBONNEAU, Claudie, NEGRIER, Sylvie, KIM, Sindy T, MOTZER, Robert J

Volltext

Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from... von Finn, Richard S, Crown, John P, Ettl, Johannes, Schmidt, Marcus, Bondarenko, Igor M, Lang, Istvan, Pinter, Tamas, Boer, Katalin, Patel, Ravindranath, Randolph, Sophia, Kim, Sindy T, Huang, Xin, Schnell, Patrick, Nadanaciva, Sashi, Bartlett, Cynthia Huang, Slamon, Dennis J

Volltext

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma von Motzer, Robert J, Hutson, Thomas E, Tomczak, Piotr, Michaelson, M. Dror, Bukowski, Ronald M, Rixe, Olivier, Oudard, Stéphane, Negrier, Sylvie, Szczylik, Cezary, Kim, Sindy T, Chen, Isan, Bycott, Paul W, Baum, Charles M, Figlin, Robert A

Volltext

Sunitinib in Patients With Metastatic Renal Cell Carcinoma von Motzer, Robert J, Rini, Brian I, Bukowski, Ronald M, Curti, Brendan D, George, Daniel J, Hudes, Gary R, Redman, Bruce G, Margolin, Kim A, Merchan, Jaime R, Wilding, George, Ginsberg, Michelle S, Bacik, Jennifer, Kim, Sindy T, Baum, Charles M, Michaelson, M. Dror

Volltext

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma von Motzer, Robert J, Hutson, Thomas E, Tomczak, Piotr, Michaelson, M Dror, Bukowski, Ronald M, Oudard, Stéphane, Negrier, Sylvie, Szczylik, Cezary, Pili, Roberto, Bjarnason, Georg A, Garcia-Del-Muro, Xavier, Sosman, Jeffrey A, Solska, Ewa, Wilding, George, Thompson, John A, Kim, Sindy T, Chen, Isan, Huang, Xin, Figlin, Robert A

Volltext

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma von Motzer, Robert J., Bukowski, Ronald M., Figlin, Robert A., Hutson, Thomas E., Michaelson, M. Dror, Kim, Sindy T., Baum, Charles M., Kattan, Michael W.

Volltext

Analyzing the Pivotal Trial That Compared Sunitinib and IFN-α in Renal Cell Carcinoma, Using a Method That Assesses Tumor Regression and Growth von STEIN, Wilfred D, WILKERSON, Julia, KIM, Sindy T, XIN HUANG, MOTZER, Robert J, TITO FOJO, Antonio, BATES, Susan E

Volltext

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma von Harmon, Charles S., DePrimo, Samuel E., Figlin, Robert A., Hudes, Gary R., Hutson, Thomas E., Michaelson, M. Dror, Négrier, Sylvie, Kim, Sindy T., Huang, Xin, Williams, J. Andrew, Eisen, Tim, Motzer, Robert J.

Volltext

Using the Rasch Model to Validate and Enhance the Interpretation of the Functional Assessment of Cancer Therapy–Kidney Symptom Index—Disease-Related Symptoms Scale von Luo, Xuemei, PhD, Cappelleri, Joseph C., MS, MPH, PhD, Cella, David, PhD, Li, Jim Z., MD, PhD, Charbonneau, Claudie, MS, Kim, Sindy T., BS, Chen, Isan, PhD, Motzer, Robert J., MD

Volltext

Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer von Gervais, Radj, Hainsworth, John D, Blais, Normand, Besse, Benjamin, Laskin, Janessa, Hamm, John T, Lipton, Allan, Albain, Kathy S, Masters, Gregory A, Natale, Ronald B, Selaru, Paulina, Kim, Sindy T, Chao, Richard C, Page, Ray D

Volltext

Phase I/II trial of sunitinib plus gefitinib in patients with metastatic renal cell carcinoma von Motzer, Robert J, Hudes, Gary R, Ginsberg, Michelle S, Baum, Michael S, Harmon, Charles S, Kim, Sindy T, Chen, Isan, Redman, Bruce G

Volltext

Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results von Heath, Elisabeth I., Blumenschein, George R., Cohen, Roger B., LoRusso, Patricia M., LoConte, Noelle K., Kim, Sindy T., Ruiz-Garcia, Ana, Chao, Richard C., Wilding, George

Volltext

Quality of Life Predicts Progression-Free Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib Versus Interferon Alfa von Cella, David, Cappelleri, Joseph C, Bushmakin, Andrew, Charbonneau, Claudie, Li, Jim Z, Kim, Sindy T, Chen, Isan, Michaelson, M. Dror, Motzer, Robert J

Volltext

Patients with Metastatic Renal Cell Carcinoma with Long-Term Disease-Free Survival After Treatment with Sunitinib and Resection of Residual Metastases von Rini, Brian I., Shaw, Vanessa, Rosenberg, Jonathan E., Kim, Sindy T., Chen, Isan

Volltext

Analyzing the pivotal trial that compared sunitinib and interferon alfa in renal cell carcinoma, using a method that assesses tumor regression and growth von Stein, Wilfred D., Wilkerson, Julia, Kim, Sindy T., Huang, Xin, Motzer, Robert J., Fojo, Antonio T., Bates, Susan E.

Volltext